Skip to content

Opening book details…

Can I read Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation on EtoBox?

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation by He, Zifan; Li, Anlin; Lin, Dagui; Gu, Yang; Chen, Yongjian; Ou, Qiyun; Li, Liren; Yao, Herui; Yu, Yunfang is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation about?

## Dear Editor, We and others have shown that the tumor mutation burden (TMB) and several underlying oncogenic alterations could provide clinically predictive implications for immune checkpoint inhibitor (ICI). [1][2][3] Protein tyrosine phosphatases (PTPs) consist of a variety classes, and most of them are highly mutated in multiple cancers and are closely interact with innate and acquired immunity regulating immune cell activation and differentiation. 4,5 PTP receptor T (PTPRT) has been found to be the most frequently mutated PTP gene in cancers and could predict poor prognosis; 4,6 however, the association of PTPRT mutation with clinical outcomes of ICI remains unknown. Here, we performed a comprehensive pancancer investigation to clinically validate PTPRT mutation as a predictive biomarker for ICI therapy. We collected clinical and PTPRT mutational data quantified by whole exome sequencing of 2129 cancer patients treated with ICI and 10,814 cancer patients without receiving ICI from the cBioPortal, PubMed, and The Cancer Genome Atlas. The study protocol was approved by the ethics committee of the Sun Yat-sen Memorial Hospital of Sun Yat-sen University. The requirement for infor

Who reads Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
He, Zifan; Li, Anlin; Lin, Dagui; Gu, Yang; Chen, Yongjian; Ou, Qiyun; Li, Liren; Yao, Herui; Yu, Yunfang
Publisher
Springer-Verlag; Springer (Biomed Central Ltd.); Springer Open; Heidelberg: Springer; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc.; Wiley (ISSN 2001-1326)
Published
2020
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by He, Zifan; Li, Anlin; Lin, Dagui; Gu, Yang; Chen, Yongjian; Ou, Qiyun; Li, Liren; Yao, Herui; Yu, Yunfang

Browse all works by He, Zifan; Li, Anlin; Lin, Dagui; Gu, Yang; Chen, Yongjian; Ou, Qiyun; Li, Liren; Yao, Herui; Yu, Yunfang